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preoperatively. 24% would change their treatment strategy in case of a bone 
mineral density (T-Score) between -1.5 and -2, 40% in case of a T-score be-
tween -2 and -2.5, and 29% would change their intraop strategy if a T-score 
smaller -2.5 was measured. 93% of all asked orthopaedics would change 
from cementless to cemented implants.
Conclusions: Due to the demographic change orthopaedic surgeons will be 
faced regularly with osteoporosis while performing arthroplasty, resulting in 
an increasing need for awareness regarding bone mineral density and os-
teoporosis.
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Aristotle  University of Thessaloniki, Papageorgiou General Hospital, Thessalon-
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Introduction/objectives: To compare the effects on fracture recovery of 
26 wks’ therapy with an oral antiresorptive (risedronate: RIS 35 mg QW) or a 
bone forming drug (teriparatide: TPTD 20 ug QD) started within 2 wks after 
osteosynthesis in a pertrochanteric hip fracture in patients with low bone 
mass.
Methods: 224 patients were randomized to study drug and an oral/inject-
able placebo plus calcium/vitD3 in an osteoporosis trial. The primary out-
come was bone mineral density which will be reported elsewhere. We report 
secondary (Timed Up-and-Go [TUG] test, hip pain, SF-36, safety) and explor-
atory (radiography) endpoints. Efficacy analyses of the TUG test, patient-rat-
ed health status, and hip pain 100 mm Visual Analog Scale were performed 
with a Mixed-effects Model for Repeated Measures.
Results: Mean age was 77 years and 77% were female. The teriparatide 
group completed the TUG test in a shorter time (LS means 5.7, 4.4, 3.1, and 
3.1 seconds less at 6, 12, 18, and 24 wks; overall difference p = 0.021) and 
reported less hip pain during the test (LS means 8.7, 10.6, 11.9, and 10.2 mm 
differences at 6, 12, 18, and 26 wks; overall difference p = 0.032). No sig-
nificant between-group differences in SF-36, Charnley hip pain score, abil-
ity to walk or walking aids during follow-up. No patient was radiographically 
healed at 6 wks, and 90% were healed at 12 wks in both groups. Implant fail-
ure (TPTD:7, RIS:8), loss of reduction (TPTD:2, RIS:4) or non-union (0 cases) 
showed no significant differences. Mild hypercalcemia and hyperuricemia 
were more frequent with teriparatide.
Conclusions: Patients treated with teriparatide reported less hip pain and 
shorter time to complete the TUG test than RIS between 6-26 wks. These 
outcomes were secondary.
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Introduction/objectives: Total hip arthroplasty (THA) is one of the success-
ful and cost-benefit surgical treatments. One-stage bilateral THA (BTHA) has 
a large number of advantages. While, there are concerns about the high-
er complications in this procedure. Aim of our study was to evaluate the 
 complications and outcomes of cementless one-stage BTHA in osteoarthritis 
patients.
Methods: A total of 147 patients from 2009 till 2013, were underwent one-
stage bilateral total hip arthroplasty (BTHA) in Milad and Erfan hospitals, 
Tehran, Iran. A prospective analysis of the functional outcomes and com-
plications of one-stage BTHA through Hardinge approach in patients with 
osteoarthritis performed. We evaluated all patients clinically and radiologi-
cally with serial follow-ups. A clinical hip score based upon the modified 
Harris Hip Score (MHHS) was performed preoperatively and again postop-
eratively.
Results: During period of study 89 men (60.5%) and 58 women (39.4%) with 
a mean age of 54.67 ± 7.08 years at the time of presentation were recruit-
ed. The mean surgical time was 2.8 ± 0.25 hrs. The mean hospital stay was 
3.83 ± 0.65 days. Hemoglobin level decreased significantly after operation 
(P = 0.038). There was two deep venous thrombosis, one superficial infection 
and one temporal proneal palsy but no pulmonary embolism, dislocation, 
periprosthetic fracture or heterotrophic ossification. The mean preoperative 
MHHS score was 41.64 ± 5.42 in patients. MHHS score improved to 89.26 ± 
4.68 in the last follow-up (P = 0.0001).
Conclusions: Our results recommend the use of cementless one-stage BTHA 
through Hardinge approach in patients with bilateral hip osteoarthritis.
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HIP ARTHROPLASTY IN PATIENTS WITH COMPLEX FEMORAL 
DEFORMITY AFTER SURGICAL TREATMENT OF DYSPLASIA
Tikhilov R, Shubnyakov I, Denisov A, Bliznyukov V
Vreden Russian Institute of Traumatology and Orthopaedics, Saint Peters-
burg, Russian Federation
Introduction/objectives: Patients with complex femoral deformity, including 
all deformities of the femur below lesser trochanter are serious problem of 
THA.
Analysis of mid-term results of total hip arthroplasty in patients with com-
plex deformities of the femur comparing with standard cases of primary THA 
and identify the factors influencing functional outcomes.
Methods: In Vreden Institute 73 patients with complex deformities of the 
femur underwent THA between 2001 and 2013 in different options: ar-
throplasty without femoral osteotomy (23); arthroplasty accompanied by 
great trochanteric slide osteotomy or Paavilainen technigue (37), arthro-
plasty with femoral osteotomy below the lesser trochanter (13), including 
4 - at the level of deformation, 4 - with double two-stage osteotomy and 
5 - with one-stage double osteotomy. All patients were assessed using Harris 
Hip Score before and after surgery. The results obtained in this study were 
processed using statistical methods, including correlation analysis.
Results: Harris hip score in mean follow-up 6.9 years (from 2 to 14 years) 
improved from 40.2 (95% CI 38.2 to 45.6) preoperatively up to 78.4 (95% CI 
76.7 to 83.5). The analysis of various factors influencing the results showed 
that the most significant ones were preoperative hip function and a low level 
of pain (Harris Hip Score 40-45 points), residual femoral deformation more 
than 5 degrees, the rotation centre displacement - more than 30 mm, the 
offset increasing - more than 20 mm and of limb length increasing - more 
than 30 mm.
Conclusions: Hip arthroplasty in patients with hip arthritis associated with 
complex femoral deformities is technically challenging, but using of the algo-
rithm presented by authors allows to achieve the better results.
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MEDIUM TERM OUTCOME OF CEMENTLESS TOTAL HIP 
ARTHROPLASTY IN PATIENTS WITH JUVENILE RHEUMATOID 
ARTHRITIS
Aminjavaheri S, Mortazavi SMJ, Mostafavi Tabatabaee R
Tehran University of Medical Science, Joint Reconstruction Research Center, 
Tehran, Islamic Republic of Iran
Introduction/objectives: Juvenile Rheumatoid arthritis (JRA) is the most 
common type of arthritis in children usually affecting hips severely. Most sur-
geons rarely recommend total hip arthroplasty (THA) to this group because 
of potentially high failure rate. This study aimed to evaluate outcomes of 
modern design uncemented THA via anterior approach in JRA patients with 
bilateral hip involvement. Using our institutional database.
